You are here: Industry Insights > MilliporeSigma

News List

MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office Posted americanpharmaceuticalreview
June 15, 2017
MilliporeSigma has announced that the Australian Patent Office has granted the company patent rights relating to the use of CRISPR in a genomic integration method for eukaryotic cells.
MilliporeSigma Develops New CRISPR Genome Editing Method contractpharma
May 26, 2017
Aims to provide researchers with more experimental options and faster results
MilliporeSigma Acquires Grzybowski Scientific Inventions americanpharmaceuticalreview
May 10, 2017
MilliporeSigma announced the acquisition of Grzybowski Scientific Inventions (GSI), developer of computer-aided retro-synthesis tool, Chematica.
MilliporeSigma Introduces Next-Gen High-Sensitivity Protein Detection Platform contractpharma
April 05, 2017
New SMCxPRO technology offers high speed, high sensitivity for single molecule detection
MilliporeSigma Opens Production Facility Exclusively for Meglumine in Spain americanpharmaceuticalreview
January 18, 2017
MilliporeSigma has announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.
MilliporeSigma Expands End-to-End Biodevelopment Centers in North America, China and Europe americanpharmaceuticalreview
January 11, 2017
MilliporeSigma has announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise.

Previous page 1 2 3 4 Next page